2013
DOI: 10.2337/dc13-1164
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular Autonomic Dysfunction Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes: A 10-Year Follow-up Study

Abstract: OBJECTIVEThe aim of this study was to investigate the development of severe hypoglycemia (SH) in the presence of cardiovascular autonomic neuropathy (CAN) in patients with type 2 diabetes. RESEARCH DESIGN AND METHODSFrom January 2001 to December 2002, a total of 894 patients with type 2 diabetes were enrolled. A cardiovascular autonomic function test (AFT) was performed using the following heart rate variability parameters: expiration-to-inspiration ratio, response to Valsalva maneuver, and standing. From the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
26
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 36 publications
5
26
0
Order By: Relevance
“…[26] In patients with diabetes, the extent of CAN is inversely related to survival and quality-of-life,[26, 34] and is associated with cardiovascular events, stroke, and other diabetic complications such as severe hypoglycemia and chronic kidney disease. [27, 28, 35] CAN may be detected at the time of diabetes diagnosis; poor glycemic control plays a central role in the development and progression of CAN. [26] In the present study, we used Ewing’s method to determine the extent of CAN.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[26] In patients with diabetes, the extent of CAN is inversely related to survival and quality-of-life,[26, 34] and is associated with cardiovascular events, stroke, and other diabetic complications such as severe hypoglycemia and chronic kidney disease. [27, 28, 35] CAN may be detected at the time of diabetes diagnosis; poor glycemic control plays a central role in the development and progression of CAN. [26] In the present study, we used Ewing’s method to determine the extent of CAN.…”
Section: Discussionmentioning
confidence: 99%
“…The CAN stage was defined as follows: 0, normal autonomic function; 1, early CAN; and ≥ 2, definite diagnosis of CAN. [28]…”
Section: Methodsmentioning
confidence: 99%
“…A cardiovascular autonomic function test using the Ewing method was performed in all enrolled patients at baseline. At least two abnormal results were defined as definite cardiovascular autonomic neuropathy [22]. Medication utilization was assessed for insulin, angiotensin-converting enzyme (ACE) inhibitor/angiotensin II receptor blocker (ARB), statin, fenofibrate, and aspirin from enrollment to the end of the follow-up period.…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, the presence of autonomic neuropathy attenuates the epinephrine response to hypoglycemia in the patients with diabetes after recent hypoglycemic exposure [14]. Moreover, diabetic cardiovascular autonomic neuropathy is an independent prognostic factor for the development of severe hypoglycemia in the patients with type 2 diabetes [15]. Therefore, we hypothesize that patients who have multiple co-morbidities, including renal impairment, may be more vulnerable to hypoglycemia when receiving SSRIs.…”
Section: Discussionmentioning
confidence: 99%